Behavioral and histological neuroprotection by tamoxifen after reversible focal cerebral ischemia

Experimental Neurology

Volumn 196, Issue 1, 2005, Pages 41-46

  Zhang, Yonghua ^a   Jin, Yiqiang ^a   Behr, Melissa J ^b   Feustel, Paul J ^a,c   Morrison, James P ^d   Kimelberg, Harold K ^a  

^a ORDWAY RESEARCH INSTITUTE   (United States)

^b WADSWORTH CENTER   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

^d Department of Obstetrics Gynecology   (United States)

Author keywords

Behavior; Cerebral ischemia; Infarct size; Long term protection; Neuroprotection; Rats; Reversible middle cerebral artery occlusion; Tamoxifen

Indexed keywords

EOSIN; HEMATOXYLIN; NEUROPROTECTIVE AGENT; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; COGNITIVE DEFECT; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RANK SUM TEST; RAT; SCORING SYSTEM; STAINING;

ANIMALS; BEHAVIOR, ANIMAL; ISCHEMIC ATTACK, TRANSIENT; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TAMOXIFEN;

EID: 26244450622     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2005.07.002     Document Type: Article

References (30)

1. J.B. Bederson, L.H. Pitts, S.M. Germano, M.C. Nishimura, R.L. Davis, and H.M. Bartkowski Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats Stroke 17 1986 1304 1308
2. A. Biegon, M. Brewster, H. Degani, E. Pop, D. Somjen, and A.M. Kaye A permanently charged tamoxifen derivative displays anticancer activity and improved tissue selectivity in rodents Cancer Res. 56 1996 4328 4331
3. F. Colbourne, and D. Corbett Delayed postischemic hypothermia: a six month survival study using behavioral and histological assessments of neuroprotection J. Neurosci. 15 1995 7250 7260
4. O. Derman, N.O. Kanbur, and T. Kutluk Tamoxifen treatment for pubertal gynecomastia Int. J. Adolesc. Med. Health 15 2003 359 363
5. U. Dirnagl, C. Iadecola, and M.A. Moskowitz Pathobiology of ischaemic stroke: an integrated view Trends Neurosci. 22 1999 391 397
6. C. Du, R. Hu, C.A. Csernansky, C.Y. Hsu, and D.W. Choi Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J. Cereb. Blood Flow Metab. 16 1996 195 201
7. Y. Feng, J.D. Fratkins, and M.H. LeBlanc Treatment with tamoxifen reduces hypoxic-ischemic brain injury in neonatal rats Eur. J. Pharmacol. 484 2004 65 74
8. P.J. Feustel, Y. Jin, and H.K. Kimelberg Volume regulated anion channels are the predominant contributors to release of excitatory amino acids in the ischemic cortical penumbra Stroke 35 2004 1164 1168
9. J.H. Garcia, S. Wagner, K.-F. Liu, and X.-J. Hu Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats Stroke 26 1995 627 635
10. M.D. Ginsberg Adventures in the pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection: the 2002 Thomas Willis lecture Stroke 34 2003 214 223
11. H.K. Kimelberg, P.J. Feustel, Y. Jin, J. Paquette, A. Boulos, R.W. Keller, and B.I. Tranmer Acute treatment with tamoxifen reduces ischemic damage following middle cerebral artery occlusion NeuroReport 11 2000 2675 2679
12. H.K. Kimelberg, Y. Jin, and P.J. Feustel Neuroprotective activity of tamoxifen in permanent focal ischemia J. Neurosurg. 99 2003 138 142
13. - and taurine efflux from HeLa cells by P-glycoprotein blockers correlates with calmodulin inhibition J. Biol. Chem. 269 1994 29389 29394
14. T.N. Lin, Y.Y. He, G. Wu, M. Khan, and C.Y. Hsu Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats Stroke 24 1993 117 121
15. E.Z. Longa, P.R. Weinstein, S. Carlson, and R. Cummins Reversible middle cerebral artery occlusion without craniectomy in rats Stroke 20 1989 84 91
16. S.H. Mehta, K.M. Dhandapani, L.M. De Sevilla, R.C. Webb, V.B. Mahesh, and D.W. Brann Tamoxifen, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized female rat Neuroendocrinology 77 2003 44 50
17. A. Mitani, and K. Kataoka Critical levels of extracellular glutamate mediating gerbil hippocampal delayed neuronal death during hypothermia: brain microdialysis study Neuroscience 42 1991 661 670
18. N. Miyasaka, T. Kuroiwa, F.Y. Zhao, T. Nagaoka, H. Akimoto, I. Yamada, T. Kubota, and T. Aso Cerebral ischemic hypoxia: discrepancy between apparent diffusion coefficients and histologic changes in rats Radiology 215 2000 199 204
19. K. Nishigaya, Y. Yoshida, M. Sasuga, H. Nukui, and G. Ooneda Effect of recirculation on exacerbation of ischemic vascular lesions in rat brain Stroke 22 1991 635 642
20. T. Obata, and S. Kubota Protective effect of tamoxifen on 1-methyl-4-phenylpyridine-induced hydroxyl radical generation in the rat striatum Neurosci. Lett. 308 2001 87 90
21. K. Osuka, P.J. Feustel, A.A. Mongin, B.I. Tranmer, and H.K. Kimelberg Tamoxifen inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat J. Neurochem. 76 2001 1842 1850
22. A.J. Owen, S. Ijaz, H. Miyashita, T. Wishart, W. Howlett, and A. Shuaib Zonisamide as a neuroprotective agent in an adult gerbil model of global forebrain ischemia: a histological, in vivo microdialysis and behavioral study Brain Res. 770 1997 115 122
23. E.A. Perez, D.R. Gandara, M.J. Edelman, R. O'Donnell, I.J. Lauder, and M. DeGregorio Phase I trial of high-dose tamoxifen in combination with cisplatin in patients with lung cancer and other advanced malignancies Cancer Invest. 21 2003 1 6
24. J.W. Phillis, D. Song, and M.H. O'Regan Tamoxifen, a chloride channel blocker, reduces glutamate and aspartate release from the ischemic cerebral cortex Brain Res. 780 1998 352 355
25. A. Renodon, J.L. Boucher, M.A. Sari, M. Delaforge, J. Ouazzani, and D. Mansuy Strong inhibition of neuronal nitric oxide synthase by the calmodulin antagonist and anti-estrogen drug tamoxifen Biochem. Pharmacol. 54 1997 1109 1114
26. 3H]aspartate release from primary astrocyte cultures Am. J. Physiol.: Cell Physiol. 274 1998 C1511 C1520
27. B.K. Siesjo, and T. Wieloch B.K. Siesjo T. Wieloch Cellular and Molecular Mechanisms of Ischemic Brain Damage 1996 Lippincott-Raven Philadelphia, NY
28. J. Valtysson, L. Hillered, P. Andine, H. Hagberg, and L. Persson Neuropathological endpoints in experimental stroke pharmacotherapy: the importance of both early and late evaluation Acta Neurochir. (Wien.) 129 1994 58 63
29. H. Wiseman, M. Cannon, H.R. Arnstein, and B. Halliwell Tamoxifen inhibits lipid peroxidation in cardiac microsomes. Comparison with liver microsomes and potential relevance to the cardiovascular benefits associated with cancer prevention and treatment by tamoxifen Biochem. Pharmacol. 45 1993 1851 1855
30. R.L. Zhang, M. Chopp, H. Chen, and J.H. Garcia Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat J. Neurol. Sci. 125 1994 3 10